Autopsy report · NCT05693090

Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

“This study was withdrawn due to a strategic business decision; no patients were enrolled.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Kura Oncology, Inc.

Sponsor type

Industry

Conditions

NSCLC

Interventions

Tipifarnib; Osimertinib

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)
  “The study was withdrawn based on business-related matters and there are no new safety concerns related to the trial. No patients were enrolled.” (85% match in meaning)
• Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
  “This study was withdrawn for business reasons.” (79% match in meaning)
• An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)
  “Study was withdrawn prior to patient dosing based on a business decision.” (78% match in meaning)
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
  “Study was withdrawn due to scientific and business considerations.” (78% match in meaning)
• Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
  “Study was withdrawn due to lack of patient enrollment.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.